Search Results - "Patrene, K"

Refine Results
  1. 1

    Bone Marrow as a Potential Source of Hepatic Oval Cells by Petersen, B. E., Bowen, W. C., Patrene, K. D., Mars, W. M., Sullivan, A. K., Murase, N., Boggs, S. S., Greenberger, J. S., Goff, J. P.

    “…Bone marrow stem cells develop into hematopoietic and mesenchymal lineages but have not been known to participate in production of hepatocytes, biliary cells,…”
    Get full text
    Journal Article
  2. 2

    Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction by Storti, P, Bolzoni, M, Donofrio, G, Airoldi, I, Guasco, D, Toscani, D, Martella, E, Lazzaretti, M, Mancini, C, Agnelli, L, Patrene, K, Maïga, S, Franceschi, V, Colla, S, Anderson, J, Neri, A, Amiot, M, Aversa, F, David Roodman, G, Giuliani, N

    Published in Leukemia (01-08-2013)
    “…Hypoxia-inducible transcription factor-1 (HIF-1α) is overexpressed in multiple myeloma (MM) cells within the hypoxic microenvironment. Herein, we explored the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers by Colson, YL, Wren, SM, Schuchert, MJ, Patrene, KD, Johnson, PC, Boggs, SS, Ildstad, ST

    Published in The Journal of immunology (1950) (01-11-1995)
    “…Reconstitution of lethally irradiated mice with a mixture of syngeneic and allogeneic (A+B-->A) bone marrow results in multilineage mixed allogeneic chimerism,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10 by DOUGHTY, L. A, PATRENE, K. D, EVANS, C. H, BOGGS, S. S, ROBBINS, P. D

    Published in Gene therapy (01-03-1997)
    “…We have been developing both local and systemic gene therapy approaches to treat inflammatory and autoimmune diseases. To determine if systemic, constitutive…”
    Get full text
    Journal Article
  7. 7

    Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach by Colson, YL, Li, H, Boggs, SS, Patrene, KD, Johnson, PC, Ildstad, ST

    Published in The Journal of immunology (1950) (01-10-1996)
    “…For over 40 years, the association between hemopoietic chimerism and donor-specific tolerance for allografts has been recognized. However, toxicity associated…”
    Get full text
    Journal Article
  8. 8

    Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice by Li, H, Kaufman, CL, Boggs, SS, Johnson, PC, Patrene, KD, Ildstad, ST

    Published in The Journal of immunology (1950) (01-01-1996)
    “…Evidence in experimental models suggests that many autoimmune diseases can be prevented by transplantation of bone marrow from disease-resistant donors. For…”
    Get full text
    Journal Article
  9. 9

    Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow by Delfino, DV, Patrene, KD, DeLeo, AB, DeLeo, R, Herberman, RB, Boggs, SS

    Published in The Journal of immunology (1950) (01-06-1994)
    “…The role of the adhesion molecule CD44 in the development of NK cells was analyzed in a mouse long-term bone marrow culture system. After 4 wk of culture (day…”
    Get full text
    Journal Article
  10. 10

    Retroviral gene transfer and sustained expression of human arylsulfatase A by Learish, R, Ohashi, T, Robbins, P A, Bahnson, A, Boggs, S S, Patrene, K, Schwartz, B E, Gieselmann, V, Barranger, J A

    Published in Gene therapy (01-04-1996)
    “…Transduction of mouse hematopoietic stem cells and their progeny was studied using a recombinant retroviral vector (MFG-ASA) which incorporates the human…”
    Get more information
    Journal Article
  11. 11

    Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD by Cooper, M H, Patrene, K D, Vecchini, F, Austin, C A, Markus, P M, Boggs, S S

    Published in Bone marrow transplantation (Basingstoke) (01-09-1994)
    “…Studies were undertaken to determine whether the doses of FK506 that are effective for acute GVHD prophylaxis following lethal irradiation and bone marrow…”
    Get more information
    Journal Article
  12. 12

    Hematopoiesis and aging III: Anemia and a blunted erythropoietic response to hemorrhage in aged mice by Boggs, D R, Patrene, K D

    Published in American journal of hematology (01-08-1985)
    “…Whether the hematocrit normally declines in the aged or whether such a decline represents inapparent disease in addition to aging is a matter of dispute…”
    Get more information
    Journal Article
  13. 13

    Purified murine hematopoietic stem cells function longer on nonirradiated W41/Wv than on +/+ irradiated stroma by VECCHINI, F, PATRENE, K. D, BOGGS, S. S

    Published in Blood (15-03-1993)
    “…Mouse bone marrow (BM) was separated into low-density, lineage-negative, wheat germ agglutinin-positive (WGA+), Rhodamine-123 bright (Rhbright) or dim (Rhdim)…”
    Get full text
    Journal Article
  14. 14

    16,16-Dimethyl prostaglandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation by Berk, L B, Patrene, K D, Boggs, S S

    “…We evaluated the effects of 16,16-dimethyl prostaglandin E2 (dm-PGE2), with and without syngeneic bone marrow transplantation (BMT) on the survival and…”
    Get more information
    Journal Article
  15. 15

    Hypoxia-inducible factor (HIF)-1[alpha] suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction by Storti, P, Bolzoni, M, Donofrio, G, Airoldi, I, Guasco, D, Toscani, D, Martella, E, Lazzaretti, M, Mancini, C, Agnelli, L, Patrene, K, Maïga, S, Franceschi, V, Colla, S, Anderson, J, Neri, A, Amiot, M, Aversa, F, David Roodman, G, Giuliani, N

    Published in Leukemia (01-08-2013)
    “…Hypoxia-inducible transcription factor-1 (HIF-1α) is overexpressed in multiple myeloma (MM) cells within the hypoxic microenvironment. Herein, we explored the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The effect of DFMO induced uptake of [3H] putrescine on human glioma cells by REDGATE, Edward S, ALEXANDER, Dominic, MAGRA, T. Ryan, HENRETTY, Joseph S, PATRENE, Kenneth D, BOGGS, Sallie S

    Published in Journal of neuro-oncology (01-11-2001)
    “…Polyamine synthesis inhibitors, such as a-difluoromethylornithine (DFMO), inhibit tumor cell growth in vitro and in vivo. However, upon cessation of treatment,…”
    Get full text
    Journal Article
  18. 18

    Generation of natural killer cells from long-term cultures of mouse bone marrow by Vecchini, F, Delfino, D, Patrene, K D, DeLeo, A, Lu, L, Herberman, R B, Boggs, S S

    Published in Natural immunity (01-01-1993)
    “…The features of a mouse long-term bone marrow culture (LTBMC) system that produces natural killer (NK) cell activity are described. Over a 4-week period in the…”
    Get more information
    Journal Article
  19. 19

    Aging and hematopoiesis. VI. Neutrophilia and other leukocyte changes in aged mice by Boggs, D, Patrene, K, Steinberg, H

    Published in Experimental hematology (01-06-1986)
    “…The concentration of blood leukocytes rose progressively as mice aged. All blood leukocytes increased, although a greater degree of increase was seen in…”
    Get more information
    Journal Article
  20. 20

    Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma by Lu, Jing, Patrene, Kenneth D, Appasamy, Pierette M, Herberman, Ronald B, Boggs, Sallie S

    Published in Experimental hematology (01-06-1999)
    “…Nonstimulated fetal liver (FL) from 14.5-day gestation mice had no natural killer (NK) cell activity and <3% expressed NK1.1. Even after short-term (3–4 day)…”
    Get full text
    Journal Article